Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02680639 · ClinicalTrials.gov registry record · NA

The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants

A NA study, sponsored by Philips Respironics.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT02680639 is a NA study that was terminated before completion, run by Philips Respironics. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02680639, a NA study, was terminated before completion, sponsored by Philips Respironics.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality throughout the world, being the fourth leading cause of death in the world. This study is designed to detect COPD participants with Expiratory Flow Limitation. EFL occurs when the airways become compressed which usually results when a pressure outside the airway exceeds the pressure inside the airway. Participants will undergo study eligibility procedures at visit 1. At visit 2 participants will undergo a baseline auto-EPAP (Expiratory Positive Airway Pressure) measurement. Then the order will be randomized to three different treatment methods. Between each treatment there will be at least a 10 minute washout period in order for CO2 to stabilize and return to baseline.

Interventions

  • DEVICE BiPAP Synchrony ventilator

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-11-13
Est. Completion 2016-08-24
Phase NA

Sponsor

Philips Respironics

35 total trials

What the Registry Record Tells You About NCT02680639

The ClinicalTrials.gov registry entry for NCT02680639 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BiPAP Synchrony ventilator is the first listed.

NCT02680639 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02680639 about?

NCT02680639 is a clinical study titled "The Use of High Frequency Oscillations With NIV in Hypercapnic COPD Participants". Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity and mortality throughout the world, being the fourth leading cause of death in the world. This study is designed to detect COPD participants with Expiratory Flow Limitation. EFL occurs when the airways become compres...

What is the current status of trial NCT02680639?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-11-13. Estimated completion is 2016-08-24.

What interventions are being tested in trial NCT02680639?

The interventions under investigation include: BiPAP Synchrony ventilator (DEVICE).

Who is sponsoring clinical trial NCT02680639?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.